Magdi E. A. Zaki

Pyrazolopyranopyrimidines as a Class of Anti-Inflammatory Agents

Magdi E. A. Zaki, Hanan A. Soliman, Ola A. Hiekal et al. · Zeitschrift für Naturforschung C · 2006 · 281 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Synthesis of Pyrazolo[4′,3′:5,6]pyrano[2,3‐<i>d</i>]pyrimidine Derivatives for Antiviral Evaluation

Ahmed H. Shamroukh, Magdi E. A. Zaki, Eman M. H. Morsy et al. · Archiv der Pharmazie · 2007 · 104 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Synthesis, Isomerization, and Antimicrobial Evaluation of Some Pyrazolopyranotriazolopyrimidine Derivatives

Ahmed H. Shamroukh, Magdi E. A. Zaki, Eman M. H. Morsy et al. · Archiv der Pharmazie · 2007 · 69 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +10

Discovery of novel indolyl-1,2,4-triazole hybrids as potent vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors with potential anti-renal cancer activity

Sami A. Al‐Hussain, Thoraya A. Farghaly, Magdi E. A. Zaki et al. · Bioorganic Chemistry · 2020 · 59 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Synthesis and Molecular Docking of Some Novel 3-Thiazolyl-Coumarins as Inhibitors of VEGFR-2 Kinase

Tariq Z. Abolibda, Maher Fathalla, Basant Farag et al. · Molecules · 2023 · 56 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17